CATALYST DOSSIER · UPDATED 2026-11-06
$PHAT
biotech · convergence -6 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $PHAT?
Quantitative
Revenue (CY2026Q2) : $74.3M (+88.0% YoY)
Net Income (CY2026Q2) : $-17.6M (+76.8% YoY)
Catalysts
Multi-spoke convergence : 10 convergent signals fired: finra_short, sc13d, xbrl_ni, sec_fda, audit_extras
Risks
Position-sizing discipline : Conviction WATCH (-6 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
QBTS via tech r=+0.98 sympathetic (score 7)
ORBS via tech r=+0.98 sympathetic (score 4)
NXPI via semis r=+0.88 sympathetic (score 9)
NVDA via semis r=+0.88 sympathetic (score 8)
TU via comms r=+0.77 sympathetic (score 11)
SKYD via comms r=+0.77 sympathetic (score 7)
Signals Firing
finra_short sc13d xbrl_ni sec_fda audit_extras auto_macro_adp_payrolls auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-26 sec_clean_gappers +4.0% +0.8% ✓ hit 2026-10-26 sec_top_gappers +4.0% +0.8% ✓ hit 2026-10-26 sec_top_moat_emerging +4.0% +0.8% ✓ hit 2026-09-29 sec_clean_gappers +1.9% -0.8% — 2026-09-29 sec_top_gappers +1.9% -0.8% — 2026-09-29 sec_top_moat_emerging +1.9% -0.8% —
Lifetime: 3/6 wins · hit-rate 50.0% on +2% intraday
Sympathy Basket QBTS via tech · score 7 ORBS via tech · score 4 NXPI via semis · score 9 NVDA via semis · score 8 TU via comms · score 11 SKYD via comms · score 7
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.